Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 29 entries
Sorted by: Best Match Show Resources per page
Managing hypertension in cardiology practice: from individual risk factors and the metabolic syndrome to global cardiometabolic risk.

International journal of clinical practice

Dominguez-Rodriguez A.
PMID: 18793373
Int J Clin Pract. 2008 Sep;62(9):1303-4. doi: 10.1111/j.1742-1241.2008.01836.x.

No abstract available.

Cite
Dominguez-Rodriguez A. Managing hypertension in cardiology practice: from individual risk factors and the metabolic syndrome to global cardiometabolic risk. Int J Clin Pract. 2008;62(9):1303-4doi: 10.1111/j.1742-1241.2008.01836.x.
Dominguez-Rodriguez, A. (2008). Managing hypertension in cardiology practice: from individual risk factors and the metabolic syndrome to global cardiometabolic risk. International journal of clinical practice, 62(9), 1303-4. https://doi.org/10.1111/j.1742-1241.2008.01836.x
Dominguez-Rodriguez, A. "Managing hypertension in cardiology practice: from individual risk factors and the metabolic syndrome to global cardiometabolic risk." International journal of clinical practice vol. 62,9 (2008): 1303-4. doi: https://doi.org/10.1111/j.1742-1241.2008.01836.x
Dominguez-Rodriguez A. Managing hypertension in cardiology practice: from individual risk factors and the metabolic syndrome to global cardiometabolic risk. Int J Clin Pract. 2008 Sep;62(9):1303-4. doi: 10.1111/j.1742-1241.2008.01836.x. PMID: 18793373.
Copy Download .nbib Format: NLM
The Complex Role of Store Operated Calcium Entry Pathways and Related Proteins in the Function of Cardiac, Skeletal and Vascular Smooth Muscle Cells.

Frontiers in physiology

Avila-Medina J, Mayoral-Gonzalez I, Dominguez-Rodriguez A, Gallardo-Castillo I, Ribas J, Ordoñez A, Rosado JA, Smani T.
PMID: 29618985
Front Physiol. 2018 Mar 21;9:257. doi: 10.3389/fphys.2018.00257. eCollection 2018.

Cardiac, skeletal, and smooth muscle cells shared the common feature of contraction in response to different stimuli. Agonist-induced muscle's contraction is triggered by a cytosolic free Ca

Cite
Avila-Medina J, Mayoral-Gonzalez I, Dominguez-Rodriguez A, et al. The Complex Role of Store Operated Calcium Entry Pathways and Related Proteins in the Function of Cardiac, Skeletal and Vascular Smooth Muscle Cells. Front Physiol. 2018;9:257doi: 10.3389/fphys.2018.00257.
Avila-Medina, J., Mayoral-Gonzalez, I., Dominguez-Rodriguez, A., Gallardo-Castillo, I., Ribas, J., Ordoñez, A., Rosado, J. A., & Smani, T. (2018). The Complex Role of Store Operated Calcium Entry Pathways and Related Proteins in the Function of Cardiac, Skeletal and Vascular Smooth Muscle Cells. Frontiers in physiology, 9257. https://doi.org/10.3389/fphys.2018.00257
Avila-Medina, Javier, et al. "The Complex Role of Store Operated Calcium Entry Pathways and Related Proteins in the Function of Cardiac, Skeletal and Vascular Smooth Muscle Cells." Frontiers in physiology vol. 9 (2018): 257. doi: https://doi.org/10.3389/fphys.2018.00257
Avila-Medina J, Mayoral-Gonzalez I, Dominguez-Rodriguez A, Gallardo-Castillo I, Ribas J, Ordoñez A, Rosado JA, Smani T. The Complex Role of Store Operated Calcium Entry Pathways and Related Proteins in the Function of Cardiac, Skeletal and Vascular Smooth Muscle Cells. Front Physiol. 2018 Mar 21;9:257. doi: 10.3389/fphys.2018.00257. eCollection 2018. PMID: 29618985; PMCID: PMC5872157.
Copy Download .nbib Format: NLM
Clinical impact of intracoronary abciximab in patients undergoing primary percutaneous coronary intervention: an individual patient data pooled analysis of randomised studies.

Heart (British Cardiac Society)

Piccolo R, Gu YL, Iversen AZ, Dominguez-Rodriguez A, de Smet BJ, Mahmoud KD, Eitel I, Abreu-Gonzalez P, Thiele H, Piscione F.
PMID: 22397943
Heart. 2012 May 24; doi: 10.1136/heartjnl-2011-301101. Epub 2012 May 24.

OBJECTIVES: The aim of this study was to perform an individual patient-level pooled analysis of randomised trials, comparing intracoronary versus intravenous abciximab bolus use in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).BACKGROUND: Abciximab...

Cite
Piccolo R, Gu YL, Iversen AZ, et al. Clinical impact of intracoronary abciximab in patients undergoing primary percutaneous coronary intervention: an individual patient data pooled analysis of randomised studies. Heart. 2012;doi: 10.1136/heartjnl-2011-301101.
Piccolo, R., Gu, Y. L., Iversen, A. Z., Dominguez-Rodriguez, A., de Smet, B. J., Mahmoud, K. D., Eitel, I., Abreu-Gonzalez, P., Thiele, H., & Piscione, F. (2012). Clinical impact of intracoronary abciximab in patients undergoing primary percutaneous coronary intervention: an individual patient data pooled analysis of randomised studies. Heart (British Cardiac Society), . https://doi.org/10.1136/heartjnl-2011-301101
Piccolo, Raffaele, et al. "Clinical impact of intracoronary abciximab in patients undergoing primary percutaneous coronary intervention: an individual patient data pooled analysis of randomised studies." Heart (British Cardiac Society) vol. (2012). doi: https://doi.org/10.1136/heartjnl-2011-301101
Piccolo R, Gu YL, Iversen AZ, Dominguez-Rodriguez A, de Smet BJ, Mahmoud KD, Eitel I, Abreu-Gonzalez P, Thiele H, Piscione F. Clinical impact of intracoronary abciximab in patients undergoing primary percutaneous coronary intervention: an individual patient data pooled analysis of randomised studies. Heart. 2012 May 24; doi: 10.1136/heartjnl-2011-301101. Epub 2012 May 24. PMID: 22397943.
Copy Download .nbib Format: NLM
Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer.

Cancer research

Harris RJ, Cheung A, Ng JCF, Laddach R, Chenoweth AM, Crescioli S, Fittall M, Dominguez-Rodriguez D, Roberts J, Levi D, Liu F, Alberts E, Quist J, Santaolalla A, Pinder SE, Gillett C, Hammar N, Irshad S, Van Hemelrijck M, Dunn-Walters DK, Fraternali F, Spicer JF, Lacy KE, Tsoka S, Grigoriadis A, Tutt ANJ, Karagiannis SN.
PMID: 34224371
Cancer Res. 2021 Aug 15;81(16):4290-4304. doi: 10.1158/0008-5472.CAN-20-3773. Epub 2021 Jun 15.

In breast cancer, humoral immune responses may contribute to clinical outcomes, especially in more immunogenic subtypes. Here, we investigated B lymphocyte subsets, immunoglobulin expression, and clonal features in breast tumors, focusing on aggressive triple-negative breast cancers (TNBC). In samples...

Cite
Harris RJ, Cheung A, Ng JCF, et al. Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer. Cancer Res. 2021;81(16):4290-4304doi: 10.1158/0008-5472.CAN-20-3773.
Harris, R. J., Cheung, A., Ng, J. C. F., Laddach, R., Chenoweth, A. M., Crescioli, S., Fittall, M., Dominguez-Rodriguez, D., Roberts, J., Levi, D., Liu, F., Alberts, E., Quist, J., Santaolalla, A., Pinder, S. E., Gillett, C., Hammar, N., Irshad, S., Van Hemelrijck, M., Dunn-Walters, D. K., Fraternali, F., Spicer, J. F., Lacy, K. E., Tsoka, S., Grigoriadis, A., Tutt, A. N. J., & Karagiannis, S. N. (2021). Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer. Cancer research, 81(16), 4290-4304. https://doi.org/10.1158/0008-5472.CAN-20-3773
Harris, Robert J, et al. "Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer." Cancer research vol. 81,16 (2021): 4290-4304. doi: https://doi.org/10.1158/0008-5472.CAN-20-3773
Harris RJ, Cheung A, Ng JCF, Laddach R, Chenoweth AM, Crescioli S, Fittall M, Dominguez-Rodriguez D, Roberts J, Levi D, Liu F, Alberts E, Quist J, Santaolalla A, Pinder SE, Gillett C, Hammar N, Irshad S, Van Hemelrijck M, Dunn-Walters DK, Fraternali F, Spicer JF, Lacy KE, Tsoka S, Grigoriadis A, Tutt ANJ, Karagiannis SN. Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer. Cancer Res. 2021 Aug 15;81(16):4290-4304. doi: 10.1158/0008-5472.CAN-20-3773. Epub 2021 Jun 15. PMID: 34224371; PMCID: PMC7611538.
Copy Download .nbib Format: NLM
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).

European heart journal. Cardiovascular pharmacotherapy

Rossello X, Raposeiras-Roubin S, Latini R, Dominguez-Rodriguez A, Barrabés JA, Sánchez PL, Anguita M, Fernández-Vázquez F, Pascual-Figal D, De la Torre Hernandez JM, Ferraro S, Vetrano A, Pérez-Rivera JA, Prada-Delgado O, Escalera N, Staszewsky L, Pizarro G, Agüero J, Pocock S, Ottani F, Fuster V, Ibáñez B.
PMID: 34351426
Eur Heart J Cardiovasc Pharmacother. 2021 Aug 05; doi: 10.1093/ehjcvp/pvab060. Epub 2021 Aug 05.

BACKGROUND: There is a lack of evidence regarding the benefits of β-blocker treatment after invasively managed acute myocardial infarction (MI) without reduced left ventricular ejection fraction (LVEF).METHODS AND RESULTS: TREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fraction...

Cite
Rossello X, Raposeiras-Roubin S, Latini R, et al. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT). Eur Heart J Cardiovasc Pharmacother. 2021;doi: 10.1093/ehjcvp/pvab060.
Rossello, X., Raposeiras-Roubin, S., Latini, R., Dominguez-Rodriguez, A., Barrabés, J. A., Sánchez, P. L., Anguita, M., Fernández-Vázquez, F., Pascual-Figal, D., De la Torre Hernandez, J. M., Ferraro, S., Vetrano, A., Pérez-Rivera, J. A., Prada-Delgado, O., Escalera, N., Staszewsky, L., Pizarro, G., Agüero, J., Pocock, S., Ottani, F., Fuster, V., Ibáñez, B. (2021). Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT). European heart journal. Cardiovascular pharmacotherapy, . https://doi.org/10.1093/ehjcvp/pvab060
Rossello, Xavier, et al. "Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)." European heart journal. Cardiovascular pharmacotherapy vol. (2021). doi: https://doi.org/10.1093/ehjcvp/pvab060
Rossello X, Raposeiras-Roubin S, Latini R, Dominguez-Rodriguez A, Barrabés JA, Sánchez PL, Anguita M, Fernández-Vázquez F, Pascual-Figal D, De la Torre Hernandez JM, Ferraro S, Vetrano A, Pérez-Rivera JA, Prada-Delgado O, Escalera N, Staszewsky L, Pizarro G, Agüero J, Pocock S, Ottani F, Fuster V, Ibáñez B. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT). Eur Heart J Cardiovasc Pharmacother. 2021 Aug 05; doi: 10.1093/ehjcvp/pvab060. Epub 2021 Aug 05. PMID: 34351426.
Copy Download .nbib Format: NLM
Unified protocol for anxiety disorders in two cities of Mexico measuring gamma activity: Study protocol for a randomized controlled trial.

Contemporary clinical trials communications

Dominguez-Rodriguez A, Chavez-Valdez SM, Avitia GC, Valencia-Espinoza LC.
PMID: 32274440
Contemp Clin Trials Commun. 2020 Mar 17;18:100556. doi: 10.1016/j.conctc.2020.100556. eCollection 2020 Jun.

BACKGROUND: The Unified Protocol for Emotional Disorders (UP) for emotional regulation manifests effective results in a broad range of mental disorders. The UP efficacy was tested in several countries, but it has not been tested within Mexican population. It...

Cite
Dominguez-Rodriguez A, Chavez-Valdez SM, Avitia GC, et al. Unified protocol for anxiety disorders in two cities of Mexico measuring gamma activity: Study protocol for a randomized controlled trial. Contemp Clin Trials Commun. 2020;18:100556doi: 10.1016/j.conctc.2020.100556.
Dominguez-Rodriguez, A., Chavez-Valdez, S. M., Avitia, G. C., & Valencia-Espinoza, L. C. (2020). Unified protocol for anxiety disorders in two cities of Mexico measuring gamma activity: Study protocol for a randomized controlled trial. Contemporary clinical trials communications, 18100556. https://doi.org/10.1016/j.conctc.2020.100556
Dominguez-Rodriguez, A, et al. "Unified protocol for anxiety disorders in two cities of Mexico measuring gamma activity: Study protocol for a randomized controlled trial." Contemporary clinical trials communications vol. 18 (2020): 100556. doi: https://doi.org/10.1016/j.conctc.2020.100556
Dominguez-Rodriguez A, Chavez-Valdez SM, Avitia GC, Valencia-Espinoza LC. Unified protocol for anxiety disorders in two cities of Mexico measuring gamma activity: Study protocol for a randomized controlled trial. Contemp Clin Trials Commun. 2020 Mar 17;18:100556. doi: 10.1016/j.conctc.2020.100556. eCollection 2020 Jun. PMID: 32274440; PMCID: PMC7136174.
Copy Download .nbib Format: NLM
Measuring soluble CD40 ligand: it is a fancy prognostic biomarker in STEMI-patients?.

Annals of translational medicine

Dominguez-Rodriguez A.
PMID: 27867993
Ann Transl Med. 2016 Oct;4:S25. doi: 10.21037/atm.2016.10.53.

No abstract available.

Cite
Dominguez-Rodriguez A. Measuring soluble CD40 ligand: it is a fancy prognostic biomarker in STEMI-patients?. Ann Transl Med. 2016;4:S25doi: 10.21037/atm.2016.10.53.
Dominguez-Rodriguez, A. (2016). Measuring soluble CD40 ligand: it is a fancy prognostic biomarker in STEMI-patients?. Annals of translational medicine, 4S25. https://doi.org/10.21037/atm.2016.10.53
Dominguez-Rodriguez, Alberto. "Measuring soluble CD40 ligand: it is a fancy prognostic biomarker in STEMI-patients?." Annals of translational medicine vol. 4 (2016): S25. doi: https://doi.org/10.21037/atm.2016.10.53
Dominguez-Rodriguez A. Measuring soluble CD40 ligand: it is a fancy prognostic biomarker in STEMI-patients?. Ann Transl Med. 2016 Oct;4:S25. doi: 10.21037/atm.2016.10.53. PMID: 27867993; PMCID: PMC5104640.
Copy Download .nbib Format: NLM
Increased heart rate and atherosclerosis: potential implications of ivabradine therapy.

World journal of cardiology

Dominguez-Rodriguez A, Blanco-Palacios G, Abreu-Gonzalez P.
PMID: 21526046
World J Cardiol. 2011 Apr 26;3(4):101-4. doi: 10.4330/wjc.v3.i4.101.

Despite all the therapeutic advances in the field of cardiology, cardiovascular diseases, and in particular coronary artery disease, remain the leading cause of death and disability worldwide, thereby underlining the importance of acquiring new therapeutic options in this field....

Cite
Dominguez-Rodriguez A, Blanco-Palacios G, Abreu-Gonzalez P. Increased heart rate and atherosclerosis: potential implications of ivabradine therapy. World J Cardiol. 2011;3(4):101-4doi: 10.4330/wjc.v3.i4.101.
Dominguez-Rodriguez, A., Blanco-Palacios, G., & Abreu-Gonzalez, P. (2011). Increased heart rate and atherosclerosis: potential implications of ivabradine therapy. World journal of cardiology, 3(4), 101-4. https://doi.org/10.4330/wjc.v3.i4.101
Dominguez-Rodriguez, Alberto, et al. "Increased heart rate and atherosclerosis: potential implications of ivabradine therapy." World journal of cardiology vol. 3,4 (2011): 101-4. doi: https://doi.org/10.4330/wjc.v3.i4.101
Dominguez-Rodriguez A, Blanco-Palacios G, Abreu-Gonzalez P. Increased heart rate and atherosclerosis: potential implications of ivabradine therapy. World J Cardiol. 2011 Apr 26;3(4):101-4. doi: 10.4330/wjc.v3.i4.101. PMID: 21526046; PMCID: PMC3082732.
Copy Download .nbib Format: NLM
Ionic conductivity of ZrO2-12 mol % Y2O3 single crystals.

Physical review. B, Condensed matter

Cachadiña I, Dominguez-Rodriguez A, Solier JD.
PMID: 10008818
Phys Rev B Condens Matter. 1993 Aug 01;48(6):3704-3712. doi: 10.1103/physrevb.48.3704.

No abstract available.

Cite
Cachadiña I, Dominguez-Rodriguez A, Solier JD. Ionic conductivity of ZrO2-12 mol % Y2O3 single crystals. Phys Rev B Condens Matter. 1993;48(6):3704-3712doi: 10.1103/physrevb.48.3704.
Cachadiña, I., Dominguez-Rodriguez, A., & Solier, J. D. (1993). Ionic conductivity of ZrO2-12 mol % Y2O3 single crystals. Physical review. B, Condensed matter, 48(6), 3704-3712. https://doi.org/10.1103/physrevb.48.3704
Cachadiña, et al. "Ionic conductivity of ZrO2-12 mol % Y2O3 single crystals." Physical review. B, Condensed matter vol. 48,6 (1993): 3704-3712. doi: https://doi.org/10.1103/physrevb.48.3704
Cachadiña I, Dominguez-Rodriguez A, Solier JD. Ionic conductivity of ZrO2-12 mol % Y2O3 single crystals. Phys Rev B Condens Matter. 1993 Aug 01;48(6):3704-3712. doi: 10.1103/physrevb.48.3704. PMID: 10008818.
Copy Download .nbib Format: NLM
[Role of exercise testing with expired gas analysis in acute coronary syndrome and coronariography without significant lesions].

Medicina clinica

Dominguez-Rodriguez A, Abreu-Gonzalez P.
PMID: 24183114
Med Clin (Barc). 2014 Feb 20;142(4):182-3. doi: 10.1016/j.medcli.2013.05.048. Epub 2013 Oct 30.

No abstract available.

Cite
Dominguez-Rodriguez A, Abreu-Gonzalez P. Papel de las pruebas de esfuerzo con análisis de gases espirados en el síndrome coronario agudo y coronariografía sin lesiones significativas. [Role of exercise testing with expired gas analysis in acute coronary syndrome and coronariography without significant lesions]. Med Clin (Barc). 2013;142(4):182-3doi: 10.1016/j.medcli.2013.05.048.
Dominguez-Rodriguez, A., & Abreu-Gonzalez, P. (2014). Papel de las pruebas de esfuerzo con análisis de gases espirados en el síndrome coronario agudo y coronariografía sin lesiones significativas. [Role of exercise testing with expired gas analysis in acute coronary syndrome and coronariography without significant lesions]. Medicina clinica, 142(4), 182-3. https://doi.org/10.1016/j.medcli.2013.05.048
Dominguez-Rodriguez, Alberto, and Abreu-Gonzalez, Pedro. "Papel de las pruebas de esfuerzo con análisis de gases espirados en el síndrome coronario agudo y coronariografía sin lesiones significativas." [Role of exercise testing with expired gas analysis in acute coronary syndrome and coronariography without significant lesions]. Medicina clinica vol. 142,4 (2014): 182-3. doi: https://doi.org/10.1016/j.medcli.2013.05.048
Dominguez-Rodriguez A, Abreu-Gonzalez P. Papel de las pruebas de esfuerzo con análisis de gases espirados en el síndrome coronario agudo y coronariografía sin lesiones significativas. [Role of exercise testing with expired gas analysis in acute coronary syndrome and coronariography without significant lesions]. Med Clin (Barc). 2014 Feb 20;142(4):182-3. doi: 10.1016/j.medcli.2013.05.048. Epub 2013 Oct 30. Spanish. PMID: 24183114.
Copy Download .nbib Format: NLM
A Self-Applied Multi-Component Psychological Online Intervention Based on UX, for the Prevention of Complicated Grief Disorder in the Mexican Population During the COVID-19 Outbreak: Protocol of a Randomized Clinical Trial.

Frontiers in psychology

Dominguez-Rodriguez A, Martínez-Luna SC, Hernández Jiménez MJ, De La Rosa-Gómez A, Arenas-Landgrave P, Esquivel Santoveña EE, Arzola-Sánchez C, Alvarez Silva J, Solis Nicolas AM, Colmenero Guadián AM, Ramírez-Martínez FR, Vargas ROC.
PMID: 33854466
Front Psychol. 2021 Mar 29;12:644782. doi: 10.3389/fpsyg.2021.644782. eCollection 2021.

No abstract available.

Cite
Dominguez-Rodriguez A, Martínez-Luna SC, Hernández Jiménez MJ, et al. A Self-Applied Multi-Component Psychological Online Intervention Based on UX, for the Prevention of Complicated Grief Disorder in the Mexican Population During the COVID-19 Outbreak: Protocol of a Randomized Clinical Trial. Front Psychol. 2021;12:644782doi: 10.3389/fpsyg.2021.644782.
Dominguez-Rodriguez, A., Martínez-Luna, S. C., Hernández Jiménez, M. J., De La Rosa-Gómez, A., Arenas-Landgrave, P., Esquivel Santoveña, E. E., Arzola-Sánchez, C., Alvarez Silva, J., Solis Nicolas, A. M., Colmenero Guadián, A. M., Ramírez-Martínez, F. R., & Vargas, R. O. C. (2021). A Self-Applied Multi-Component Psychological Online Intervention Based on UX, for the Prevention of Complicated Grief Disorder in the Mexican Population During the COVID-19 Outbreak: Protocol of a Randomized Clinical Trial. Frontiers in psychology, 12644782. https://doi.org/10.3389/fpsyg.2021.644782
Dominguez-Rodriguez, Alejandro, et al. "A Self-Applied Multi-Component Psychological Online Intervention Based on UX, for the Prevention of Complicated Grief Disorder in the Mexican Population During the COVID-19 Outbreak: Protocol of a Randomized Clinical Trial." Frontiers in psychology vol. 12 (2021): 644782. doi: https://doi.org/10.3389/fpsyg.2021.644782
Dominguez-Rodriguez A, Martínez-Luna SC, Hernández Jiménez MJ, De La Rosa-Gómez A, Arenas-Landgrave P, Esquivel Santoveña EE, Arzola-Sánchez C, Alvarez Silva J, Solis Nicolas AM, Colmenero Guadián AM, Ramírez-Martínez FR, Vargas ROC. A Self-Applied Multi-Component Psychological Online Intervention Based on UX, for the Prevention of Complicated Grief Disorder in the Mexican Population During the COVID-19 Outbreak: Protocol of a Randomized Clinical Trial. Front Psychol. 2021 Mar 29;12:644782. doi: 10.3389/fpsyg.2021.644782. eCollection 2021. PMID: 33854466; PMCID: PMC8039460.
Copy Download .nbib Format: NLM
Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer.

Cancer research

Harris RJ, Cheung A, Ng JCF, Laddach R, Chenoweth AM, Crescioli S, Fittall M, Dominguez-Rodriguez D, Roberts J, Levi D, Liu F, Alberts E, Quist J, Santaolalla A, Pinder SE, Gillett C, Hammar N, Irshad S, Van Hemelrijck M, Dunn-Walters DK, Fraternali F, Spicer JF, Lacy KE, Tsoka S, Grigoriadis A, Tutt ANJ, Karagiannis SN.
PMID: 34224371
Cancer Res. 2021 Aug 15;81(16):4290-4304. doi: 10.1158/0008-5472.CAN-20-3773. Epub 2021 Jun 15.

In breast cancer, humoral immune responses may contribute to clinical outcomes, especially in more immunogenic subtypes. Here, we investigated B lymphocyte subsets, immunoglobulin expression, and clonal features in breast tumors, focusing on aggressive triple-negative breast cancers (TNBC). In samples...

Cite
Harris RJ, Cheung A, Ng JCF, et al. Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer. Cancer Res. 2021;81(16):4290-4304doi: 10.1158/0008-5472.CAN-20-3773.
Harris, R. J., Cheung, A., Ng, J. C. F., Laddach, R., Chenoweth, A. M., Crescioli, S., Fittall, M., Dominguez-Rodriguez, D., Roberts, J., Levi, D., Liu, F., Alberts, E., Quist, J., Santaolalla, A., Pinder, S. E., Gillett, C., Hammar, N., Irshad, S., Van Hemelrijck, M., Dunn-Walters, D. K., Fraternali, F., Spicer, J. F., Lacy, K. E., Tsoka, S., Grigoriadis, A., Tutt, A. N. J., & Karagiannis, S. N. (2021). Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer. Cancer research, 81(16), 4290-4304. https://doi.org/10.1158/0008-5472.CAN-20-3773
Harris, Robert J, et al. "Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer." Cancer research vol. 81,16 (2021): 4290-4304. doi: https://doi.org/10.1158/0008-5472.CAN-20-3773
Harris RJ, Cheung A, Ng JCF, Laddach R, Chenoweth AM, Crescioli S, Fittall M, Dominguez-Rodriguez D, Roberts J, Levi D, Liu F, Alberts E, Quist J, Santaolalla A, Pinder SE, Gillett C, Hammar N, Irshad S, Van Hemelrijck M, Dunn-Walters DK, Fraternali F, Spicer JF, Lacy KE, Tsoka S, Grigoriadis A, Tutt ANJ, Karagiannis SN. Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer. Cancer Res. 2021 Aug 15;81(16):4290-4304. doi: 10.1158/0008-5472.CAN-20-3773. Epub 2021 Jun 15. PMID: 34224371; PMCID: PMC7611538.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 29 entries